APC-Linked Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)
Référence MBS2058630-1mL
Conditionnement : 1mL
Marque : MyBiosource
Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2058630SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2058630 is an antibody targeting TNFSF13. Also known as APC-Linked Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13). Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13), Polyclonal Antibody
Full Product Name
APC-Linked Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)
Product Gene Name
anti-TNFSF13 antibody
Product Synonym Names
CD256; APRIL; TALL2; TRDL1; ZTNF2; A Proliferation Inducing Ligand; TNF And APOL Related Leukocyte Expressed Ligand 2; TNF-Related Death Ligand 1
Clonality
Polyclonal
Host
Rabbit
Form/Format
Liquid; Supplied as solution form in 10 mM Tris, 150 mM NaCl, pH 8.2 , 50% glycerol , 0.05% Proclin-300
Purity/Purification
Antigen-specific Affinity Chromatography
Concentration
0.25mg/mL (lot specific)
Preparation and Storage
Storage:
Avoid repeated freeze/thaw cycles.
Keep in dark place
Aliquot and store at 4 degree C for 12 months.
Stability Test:
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Avoid repeated freeze/thaw cycles.
Keep in dark place
Aliquot and store at 4 degree C for 12 months.
Stability Test:
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Matching Pairs
Unconjugated Antibody: TNFSF13 (MBS2015705)
APC Conjugated Antibody: TNFSF13 (MBS2058630)
APC Conjugated Antibody: TNFSF13 (MBS2058630)
Matching Pairs
APC Conjugated Antibody: TNFSF13 (MBS2058630)
Immunogen: TNFSF13 (MBS2018601)
Immunogen: TNFSF13 (MBS2018601)
OMIM
AF046888 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Source
Antibody labeling
Label
APC
Original Antibody
(Catalog # MBS2015705 )
Immunogen
Recombinant TNFSF13 (Ala93~Leu250) expressed in E.coli.
Note
As fluorescence can photobleach when exposed to light, so the antibody must be protected from light.
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-TNFSF13 antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) , Immunofluorescence (IF)
Application Notes for anti-TNFSF13 antibody
Western blotting: 0.5-2ug/mL
Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user.
Other Notes
Small volumes of anti-TNFSF13 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for TNFSF13. It may not necessarily be applicable to this product.
NCBI Official Full Name
tumor necrosis factor ligand superfamily member 13 isoform beta
NCBI Official Synonym Full Names
tumor necrosis factor superfamily member 13
NCBI Official Symbol
TNFSF13
NCBI Official Synonym Symbols
APRIL; CD256; TALL2; ZTNF2; TALL-2; TNLG7B; TRDL-1; UNQ383/PRO715
UniProt Protein Name
Tumor necrosis factor ligand superfamily member 13
UniProt Synonym Protein Names
A proliferation-inducing ligand; APRIL; TNF- and APOL-related leukocyte expressed ligand 2; TALL-2; TNF-related death ligand 1; TRDL-1; CD_antigen: CD256
Protein Family
Tumor necrosis factor ligand superfamily
UniProt Gene Name
TNFSF13
UniProt Synonym Gene Names
APRIL; TALL2; ZTNF2; APRIL; TALL-2; TRDL-1
NCBI Protein Information
tumor necrosis factor ligand superfamily member 13
NCBI Summary for TNFSF13
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of this gene have been identified; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
Show more UniProt Comments for TNFSF13
TNFSF13: Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes. Belongs to the tumor necrosis factor family. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Cytokine
Chromosomal Location of Human Ortholog: 17p13.1
Cellular Component: cytoplasm; cytosol; extracellular region; nucleoplasm
Molecular Function: receptor binding
Biological Process: positive regulation of cell proliferation; positive regulation of isotype switching to IgA isotypes; regulation of mRNA stability; signal transduction; tumor necrosis factor-mediated signaling pathway
Show more Protein type: Cytokine
Chromosomal Location of Human Ortholog: 17p13.1
Cellular Component: cytoplasm; cytosol; extracellular region; nucleoplasm
Molecular Function: receptor binding
Biological Process: positive regulation of cell proliferation; positive regulation of isotype switching to IgA isotypes; regulation of mRNA stability; signal transduction; tumor necrosis factor-mediated signaling pathway
Research Articles on TNFSF13
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-TNFSF13 antibody
| Reference Product | PubMed Publications |
|---|---|
| TNFSF13B antibody | >96 publications with TNFSF13 and TNFSF13B |
| TNFRSF17 antibody | >60 publications with TNFSF13 and TNFRSF17 |
| TNFRSF13B antibody | >45 publications with TNFSF13 and TNFRSF13B |
| SET antibody | >8 publications with TNFSF13 and SET |
| FURIN antibody | >5 publications with TNFSF13 and FURIN |
Pathways associated with anti-TNFSF13 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| HuR Stabilizes MRNA Pathway antibodies | HuR Stabilizes MRNA Pathway Diagram |
| Intestinal Immune Network For IgA Production Pathway antibodies | Intestinal Immune Network For IgA Production Pathway Diagram |
| Intestinal Immune Network For IgA Production Pathway antibodies | Intestinal Immune Network For IgA Production Pathway Diagram |
| Regulation Of MRNA Stability By Proteins That Bind AU-rich Elements Pathway antibodies | Regulation Of MRNA Stability By Proteins That Bind AU-rich Elements Pathway Diagram |
| Rheumatoid Arthritis Pathway antibodies | Rheumatoid Arthritis Pathway Diagram |
| Rheumatoid Arthritis Pathway antibodies | Rheumatoid Arthritis Pathway Diagram |
| Spinal Cord Injury Pathway antibodies | Spinal Cord Injury Pathway Diagram |
Diseases associated with anti-TNFSF13 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Necrosis Antibodies | >218 publications with TNFSF13 and Necrosis |
| Inflammation Antibodies | >21 publications with TNFSF13 and Inflammation |
| Disease Models, Animal Antibodies | >13 publications with TNFSF13 and Disease Models, Animal |
| Cardiovascular Diseases Antibodies | >11 publications with TNFSF13 and Cardiovascular Diseases |
| Colorectal Neoplasms Antibodies | >11 publications with TNFSF13 and Colorectal Neoplasms |
| Nervous System Diseases Antibodies | >10 publications with TNFSF13 and Nervous System Diseases |
| Kidney Diseases Antibodies | >6 publications with TNFSF13 and Kidney Diseases |
| Liver Neoplasms Antibodies | >5 publications with TNFSF13 and Liver Neoplasms |
| Neoplasms, Experimental Antibodies | >5 publications with TNFSF13 and Neoplasms, Experimental |
| Liver Diseases Antibodies | >4 publications with TNFSF13 and Liver Diseases |
Organs/Tissues associated with anti-TNFSF13 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >166 publications with TNFSF13 and Blood |
| Bone Antibodies | >22 publications with TNFSF13 and Bone |
| Spleen Antibodies | >16 publications with TNFSF13 and Spleen |
| Lung Antibodies | >11 publications with TNFSF13 and Lung |
| Kidney Antibodies | >10 publications with TNFSF13 and Kidney |
| Lymph Node Antibodies | >9 publications with TNFSF13 and Lymph Node |
| Skin Antibodies | >7 publications with TNFSF13 and Skin |
| Liver Antibodies | >6 publications with TNFSF13 and Liver |
| Vascular Antibodies | >5 publications with TNFSF13 and Vascular |
| Mouth Antibodies | >4 publications with TNFSF13 and Mouth |


